Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over time.

Filli L, Sutter T, Easthope CS, Killeen T, Meyer C, Reuter K, Lörincz L, Bolliger M, Weller M, Curt A, Straumann D, Linnebank M, Zörner B.

Sci Rep. 2018 Mar 21;8(1):4984. doi: 10.1038/s41598-018-22676-0.

2.

Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years.

Broicher SD, Filli L, Geisseler O, Germann N, Zörner B, Brugger P, Linnebank M.

J Neurol. 2018 May;265(5):1016-1025. doi: 10.1007/s00415-018-8796-9. Epub 2018 Feb 20.

PMID:
29464379
3.

Author response: Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis.

Filli L, Zörner B, Killeen T, Linnebank M.

Neurology. 2017 Sep 12;89(11):1200. doi: 10.1212/WNL.0000000000004379. Epub 2017 Sep 11. No abstract available.

PMID:
28894033
4.

Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathology.

Ineichen BV, Kapitza S, Bleul C, Good N, Plattner PS, Seyedsadr MS, Kaiser J, Schneider MP, Zörner B, Martin R, Linnebank M, Schwab ME.

Acta Neuropathol. 2017 Sep;134(3):423-440. doi: 10.1007/s00401-017-1745-3. Epub 2017 Jun 23.

5.

Minimum toe clearance: probing the neural control of locomotion.

Killeen T, Easthope CS, Demkó L, Filli L, Lőrincz L, Linnebank M, Curt A, Zörner B, Bolliger M.

Sci Rep. 2017 May 15;7(1):1922. doi: 10.1038/s41598-017-02189-y.

6.

High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis.

Ineichen BV, Schneider MP, Hlavica M, Hagenbuch N, Linnebank M, Kessler TM.

Mult Scler. 2018 Apr;24(4):529-534. doi: 10.1177/1352458517703801. Epub 2017 Apr 3.

PMID:
28367674
7.

Increasing cognitive load attenuates right arm swing in healthy human walking.

Killeen T, Easthope CS, Filli L, Lőrincz L, Schrafl-Altermatt M, Brugger P, Linnebank M, Curt A, Zörner B, Bolliger M.

R Soc Open Sci. 2017 Jan 25;4(1):160993. doi: 10.1098/rsos.160993. eCollection 2017 Jan.

8.

Intrauterine valproate exposure is associated with alterations in hippocampal cell numbers and folate metabolism in a rat model of valproate teratogenicity.

Semmler A, Frisch C, Bleul C, Smith D, Bigler L, Prost JC, Blom H, Linnebank M.

Seizure. 2017 Mar;46:7-12. doi: 10.1016/j.seizure.2017.01.003. Epub 2017 Jan 27.

9.

Cystatin F is a biomarker of prion pathogenesis in mice.

Nuvolone M, Schmid N, Miele G, Sorce S, Moos R, Schori C, Beerli RR, Bauer M, Saudan P, Dietmeier K, Lachmann I, Linnebank M, Martin R, Kallweit U, Kana V, Rushing EJ, Budka H, Aguzzi A.

PLoS One. 2017 Feb 8;12(2):e0171923. doi: 10.1371/journal.pone.0171923. eCollection 2017.

10.

Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis.

Filli L, Zörner B, Kapitza S, Reuter K, Lörincz L, Weller D, Sutter T, Killeen T, Gruber P, Petersen JA, Weller M, Linnebank M.

Neurology. 2017 Feb 28;88(9):832-841. doi: 10.1212/WNL.0000000000003656. Epub 2017 Feb 1.

11.

Nogo-A Antibodies for Progressive Multiple Sclerosis.

Ineichen BV, Plattner PS, Good N, Martin R, Linnebank M, Schwab ME.

CNS Drugs. 2017 Mar;31(3):187-198. doi: 10.1007/s40263-017-0407-2. Review.

12.

Sudan black: a fast, easy and non-toxic method to assess myelin repair in demyelinating diseases.

Ineichen BV, Weinmann O, Good N, Plattner PS, Wicki C, Rushing EJ, Linnebank M, Schwab ME.

Neuropathol Appl Neurobiol. 2017 Apr;43(3):242-251. doi: 10.1111/nan.12373. Epub 2017 Mar 10.

PMID:
28009439
13.

Direct, long-term intrathecal application of therapeutics to the rodent CNS.

Ineichen BV, Schnell L, Gullo M, Kaiser J, Schneider MP, Mosberger AC, Good N, Linnebank M, Schwab ME.

Nat Protoc. 2017 Jan;12(1):104-131. doi: 10.1038/nprot.2016.151. Epub 2016 Dec 15.

PMID:
27977023
14.

Novel cases of amyotrophic lateral sclerosis after treatment of cerebral arteriovenous malformationss.

Linnebank M, McDougall CG, Krueger S, Biskup S, Neumann M, Weller M, Valavanis A, Prudlo J.

Swiss Med Wkly. 2016 Nov 12;146:w14361. doi: 10.4414/smw.2016.14361. eCollection 2016.

15.

The relevance of cortical lesions in patients with multiple sclerosis.

Geisseler O, Pflugshaupt T, Bezzola L, Reuter K, Weller D, Schuknecht B, Brugger P, Linnebank M.

BMC Neurol. 2016 Oct 21;16(1):204.

16.

Considerations on long-term immuno-intervention in the treatment of multiple sclerosis: an expert opinion.

Grigoriadis N, Linnebank M, Alexandri N, Muehl S, Hofbauer GF.

Expert Opin Pharmacother. 2016 Oct;17(15):2085-95. doi: 10.1080/14656566.2016.1232712. Epub 2016 Sep 15. Review.

PMID:
27594523
17.

Modulating Arm Swing Symmetry with Cognitive Load: A Window on Rhythmic Spinal Locomotor Networks in Humans?

Killeen T, Easthope CS, Filli L, Linnebank M, Curt A, Bolliger M, Zörner B.

J Neurotrauma. 2017 May 15;34(10):1897-1902. doi: 10.1089/neu.2016.4554. Epub 2016 Oct 12.

PMID:
27574966
18.

Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta.

Oikonomidi A, Lewczuk P, Kornhuber J, Smulders Y, Linnebank M, Semmler A, Popp J.

J Neurochem. 2016 Oct;139(2):324-332. doi: 10.1111/jnc.13766. Epub 2016 Sep 30.

19.

Teaching NeuroImages: Recurrent oculomotor palsies caused by neurosarcoidosis.

Kana V, Petersen JA, Ikenberg K, Chappaz A, Gerth-Kahlert C, Appenzeller P, Linnebank M.

Neurology. 2016 Jul 19;87(3):e31-2. doi: 10.1212/WNL.0000000000002865. No abstract available.

20.

Random number generation deficits in patients with multiple sclerosis: Characteristics and neural correlates.

Geisseler O, Pflugshaupt T, Buchmann A, Bezzola L, Reuter K, Schuknecht B, Weller D, Linnebank M, Brugger P.

Cortex. 2016 Sep;82:237-243. doi: 10.1016/j.cortex.2016.05.007. Epub 2016 May 21.

21.

Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment.

Pflugshaupt T, Geisseler O, Nyffeler T, Linnebank M.

Semin Neurol. 2016 Apr;36(2):203-11. doi: 10.1055/s-0036-1579696. Epub 2016 Apr 26. Review.

PMID:
27116727
22.

Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.

Zörner B, Filli L, Reuter K, Kapitza S, Lörincz L, Sutter T, Weller D, Farkas M, Easthope CS, Czaplinski A, Weller M, Linnebank M.

Mult Scler. 2016 Oct;22(11):1463-1475. Epub 2016 Jan 13.

23.

Cortical thinning in the anterior cingulate cortex predicts multiple sclerosis patients' fluency performance in a lateralised manner.

Geisseler O, Pflugshaupt T, Bezzola L, Reuter K, Weller D, Schuknecht B, Brugger P, Linnebank M.

Neuroimage Clin. 2015 Nov 14;10:89-95. doi: 10.1016/j.nicl.2015.11.008. eCollection 2016.

24.

Neurosyphilis presenting as a new onset lateralized movement disorder.

Pfender N, Linnebank M, Sommerauer M, Tarnutzer AA.

J Clin Neurosci. 2015 Oct;22(10):1682-3. doi: 10.1016/j.jocn.2015.03.038. Epub 2015 Jun 6.

25.

Pitfalls in the diagnostic evaluation of subacute combined degeneration.

Ulrich A, Müller D, Linnebank M, Tarnutzer AA.

BMJ Case Rep. 2015 May 14;2015. pii: bcr2014208622. doi: 10.1136/bcr-2014-208622.

26.

Reactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis.

Pfender N, Jelcic I, Linnebank M, Schwarz U, Martin R.

Neurology. 2015 Jun 9;84(23):2377-8. doi: 10.1212/WNL.0000000000001659. Epub 2015 May 8. No abstract available.

27.

Alcohol abuse and cigarette smoking are associated with global DNA hypermethylation: results from the German Investigation on Neurobiology in Alcoholism (GINA).

Semmler A, Heese P, Stoffel-Wagner B, Muschler M, Heberlein A, Bigler L, Prost JC, Frieling H, Kornhuber J, Banger M, Bleich S, Hillemacher T, Linnebank M.

Alcohol. 2015 Mar;49(2):97-101. doi: 10.1016/j.alcohol.2015.01.004. Epub 2015 Jan 20.

28.

Funicular myelosis in a butcher: it was the cream cans.

Wolpert F, Baráth K, Brakowski J, Renzel R, Linnebank M, Gantenbein AR.

Case Rep Neurol Med. 2015;2015:827168. doi: 10.1155/2015/827168. Epub 2015 Jan 28.

29.

Genetic variants of methionine metabolism and DNA methylation.

Bleich S, Semmler A, Frieling H, Thumfart L, Muschler M, Hillemacher T, Kornhuber J, Kallweit U, Simon M, Linnebank M.

Epigenomics. 2014;6(6):585-91. doi: 10.2217/epi.14.54.

30.

No association between the ALDH2 promoter polymorphism rs886205, alcohol dependence, and risky alcohol consumption in a German population.

Haschemi Nassab M, Rhein M, Heese P, Glahn A, Frieling H, Linnebank M, Bleich S, Kornhuber J, Heberlein A, Grallert H, Peters A, Rawal R, Strauch K, Hillemacher T.

Psychiatr Genet. 2015 Feb;25(1):41-2. doi: 10.1097/YPG.0000000000000073. No abstract available.

31.

Clinically isolated neurosarcoidosis: a recommended diagnostic path.

Wegener S, Linnebank M, Martin R, Valavanis A, Weller M.

Eur Neurol. 2015;73(1-2):71-7. doi: 10.1159/000366199. Epub 2014 Nov 12.

32.

Bottom-up Visual Integration in the Medial Parietal Lobe.

Pflugshaupt T, Nösberger M, Gutbrod K, Weber KP, Linnebank M, Brugger P.

Cereb Cortex. 2016 Mar;26(3):943-949. doi: 10.1093/cercor/bhu256. Epub 2014 Oct 19.

33.

Reciprocal modulation of Aβ42 aggregation by copper and homocysteine.

Keskitalo S, Farkas M, Hanenberg M, Szodorai A, Kulic L, Semmler A, Weller M, Nitsch RM, Linnebank M.

Front Aging Neurosci. 2014 Sep 8;6:237. doi: 10.3389/fnagi.2014.00237. eCollection 2014.

34.

[Supporting the self efficacy of the patient].

Kunkel S, Linnebank M, Staudacher D, Spirig R.

Krankenpfl Soins Infirm. 2014;107(1):30-1. German. No abstract available.

35.

Amyotrophic lateral sclerosis after embolization of cerebral arterioveneous malformations.

Valavanis A, Schwarz U, Baumann CR, Weller M, Linnebank M.

J Neurol. 2014 Apr;261(4):732-7. doi: 10.1007/s00415-014-7260-8. Epub 2014 Feb 8.

PMID:
24509642
36.

The presence of oligoclonal IgG bands in human CSF during the course of neurological diseases.

Haertle M, Kallweit U, Weller M, Linnebank M.

J Neurol. 2014 Mar;261(3):554-60. doi: 10.1007/s00415-013-7234-2. Epub 2014 Jan 22.

37.

Genetic variants of homocysteine metabolism and multiple sclerosis: a case-control study.

Ineichen BV, Keskitalo S, Farkas M, Bain N, Kallweit U, Weller M, Klotz L, Linnebank M.

Neurosci Lett. 2014 Mar 6;562:75-8. doi: 10.1016/j.neulet.2014.01.008. Epub 2014 Jan 9.

PMID:
24412677
38.

Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association?

Kallweit U, Baumann CR, Harzheim M, Hidalgo H, Pöhlau D, Bassetti CL, Linnebank M, Valko PO.

Mult Scler Int. 2013;2013:286581. doi: 10.1155/2013/286581. Epub 2013 Oct 22.

39.

Is preeclampsia associated with restless legs syndrome?

Ramirez JO, Cabrera SA, Hidalgo H, Cabrera SG, Linnebank M, Bassetti CL, Kallweit U.

Sleep Med. 2013 Sep;14(9):894-6. doi: 10.1016/j.sleep.2013.03.013. Epub 2013 Jul 23.

40.

JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.

Schippling S, Kempf C, Büchele F, Jelcic I, Bozinov O, Bont A, Linnebank M, Sospedra M, Weller M, Budka H, Martin R.

Ann Neurol. 2013 Oct;74(4):622-6. doi: 10.1002/ana.23973. Epub 2013 Sep 16.

PMID:
23868420
41.

Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies.

Gobbi C, Zecca C, Linnebank M, Müller S, You X, Meier R, Borter E, Traber M.

Eur Neurol. 2013;70(1-2):35-41. doi: 10.1159/000346761. Epub 2013 May 14.

42.

Elevated CSF histamine levels in multiple sclerosis patients.

Kallweit U, Aritake K, Bassetti CL, Blumenthal S, Hayaishi O, Linnebank M, Baumann CR, Urade Y.

Fluids Barriers CNS. 2013 May 9;10:19. doi: 10.1186/2045-8118-10-19. eCollection 2013.

43.

Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS).

Preiningerova JL, Baumhackl U, Csepany T, Czaplinski A, Deisenhammer F, Derfuss T, Fabjan TH, Fazekas F, Fuchs S, Havrdova E, Ledinek AH, Illes Z, Jazbec SS, Klimova E, Komoly S, Kurca E, Linnebank M, Lisy L, Mares J, Prochazkova L, Csilla R, Szilasiova J, Stourac P, Talab R, Turcani P, Vachova M, Vecsei L, Vodusek D, Zapletalova O, Berger T.

CNS Neurosci Ther. 2013 May;19(5):302-6. doi: 10.1111/cns.12101.

PMID:
23607697
44.

Methylation metabolism in sepsis and systemic inflammatory response syndrome.

Semmler A, Prost JC, Smulders Y, Smith D, Blom H, Bigler L, Linnebank M.

Scand J Clin Lab Invest. 2013 Aug;73(5):368-72. doi: 10.3109/00365513.2013.785587. Epub 2013 Apr 8.

PMID:
23566119
45.

Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolism.

Semmler A, Moskau-Hartmann S, Stoffel-Wagner B, Elger C, Linnebank M.

Clin Chem Lab Med. 2013 Mar 1;51(3):665-9. doi: 10.1515/cclm-2012-0580.

46.

An efficient method for fractionated whole rodent brain radiation.

Semmler A, Garbe S, Moskau S, Frisch C, Eter N, Schlegel U, Linnebank M.

Neurol Res. 2013 May;35(4):355-9. doi: 10.1179/1743132812Y.0000000143. Epub 2013 Jan 10.

47.

Plasma homocysteine levels increase following stress in older but not younger men.

Kuebler U, Linnebank M, Semmler A, Stoffel-Wagner B, La Marca R, Ehlert U, Wirtz PH.

Psychoneuroendocrinology. 2013 Aug;38(8):1381-7. doi: 10.1016/j.psyneuen.2012.12.003. Epub 2013 Jan 9.

PMID:
23312061
48.

Chronic homocysteine exposure causes changes in the intrinsic electrophysiological properties of cultured hippocampal neurons.

Schaub C, Uebachs M, Beck H, Linnebank M.

Exp Brain Res. 2013 Apr;225(4):527-34. doi: 10.1007/s00221-012-3392-1. Epub 2013 Jan 10.

49.

A possible genetic link between MTHFR genotype and smoking behavior.

Linnebank M, Moskau S, Semmler A, Hoefgen B, Bopp G, Kallweit U, Maier W, Schütz CG, Wüllner U.

PLoS One. 2012;7(12):e53322. doi: 10.1371/journal.pone.0053322. Epub 2012 Dec 28.

50.

Hyperhomocysteinemia in Alzheimer's disease: the hen and the egg?

Farkas M, Keskitalo S, Smith DE, Bain N, Semmler A, Ineichen B, Smulders Y, Blom H, Kulic L, Linnebank M.

J Alzheimers Dis. 2013;33(4):1097-104. doi: 10.3233/JAD-2012-121378.

PMID:
23099812

Supplemental Content

Loading ...
Support Center